WaveFront is a funded search working with blue chip investors including Peterson Partners, Miramar Equity, M2O, and Shore Capital along with a number of successful search fund entrepreneurs and CEOs to acquire a business providing products or services to pharmaceutical research and the life sciences sector broadly.WaveFront was founded by a Harvard MS/MBA in Biotechnology who has worked for large pharmaceutical companies, midsize biotechs, diagnostics, and medical device companies and executed partnership transactions of $230M in cash and $13B in potential milestone payments and participated in raising >$500M in venture capital and public offerings.